BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 141 filers reported holding BIOSCRIP INC in Q2 2014. The put-call ratio across all filers is 4.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $10,000 | +25.0% | 3,700 | -21.3% | 0.00% | – |
| Q1 2017 | $8,000 | +166.7% | 4,700 | +74.1% | 0.00% | – |
| Q4 2016 | $3,000 | -62.5% | 2,700 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +14.3% | 2,700 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +16.7% | 2,700 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | +20.0% | 2,700 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -61.5% | 2,700 | -6.9% | 0.00% | – |
| Q1 2015 | $13,000 | -31.6% | 2,900 | +7.4% | 0.00% | – |
| Q4 2014 | $19,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -24.0% | 2,700 | -10.0% | 0.00% | – |
| Q2 2014 | $25,000 | +31.6% | 3,000 | +11.1% | 0.00% | – |
| Q1 2014 | $19,000 | -5.0% | 2,700 | 0.0% | 0.00% | – |
| Q4 2013 | $20,000 | -28.6% | 2,700 | -15.6% | 0.00% | -100.0% |
| Q3 2013 | $28,000 | -59.4% | 3,200 | -23.8% | 0.00% | -50.0% |
| Q2 2013 | $69,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |